This finding from a current project by the Austrian Science Fund FWF was presented at the 5th International Conference on Multiple Comparison Procedures (MCP2007) in Vienna, which recently drew to a close. The conference, held at the Medical University, focused on the increasingly important issue of boosting the efficiency of medical studies in statistical terms.
30,000 – this is the number of genes that can be analysed simultaneously with state-of-the-art instruments. Such analyses provide a means of identifying whether individual genes have a decisive impact in the course of a disease or therapy. However, the more genes that are examined in a study, the greater the probability of incorrectly identifying a gene as a factor when, in reality, it has no influence.
MORE CONCENTRATION – LESS ERRORS
Dr. Sonja Zehetmayer from the Department of Medical Statistics, Medical University of Vienna, says: "The problem of identifying factors incorrectly could be countered by a very high number of repetition. However, repetition normally needs to be kept to a minimum, owing to high costs. A more innovative approach to solve this problem is offered by multi-stage methods. These involve preselecting genes following the first examination stage. In subsequent stages, only these selected genes are subject to further analysis. Concentrating on fewer genes thereby cuts error probability."
The question of exactly how many stages are needed to deliver an optimal cost-benefit ratio has until now remained unresolved. The answer has now been calculated, published, and discussed by Dr. Zehetmayer and her colleagues at the MCP2007 held in Vienna from 8 to 11 July. In actual fact, the solution turned out to be unexpectedly straightforward – three stages deliver the optimal ratio between the accuracy of the results obtained and the costs necessary for this. Although a fourth stage would offer greater accuracy, the resources this would require are out of all proportion to the additional accuracy gained.
Dr. Zehetmayer also found surprising results when she compared two different test designs with each other: "Multi-stage series of tests can be analysed either by integrating the results of all levels or by analysing the results of only the last stage. While the choice of test design for four-stage methods has a marked effect on its statistical characteristics, this effect is mitigated in the case of a three-stage method."
Dr. Zehetmayer’s colleague Alexandra Goll presented a further aspect contributing to the optimum configuration of test methods at the MCP2007. She showed that the individual stages of multi-stage test methods can be configured very differently without having a major detrimental effect on the accuracy of the end result. This means that initial stages can clearly be more cost-effective if more accurate and more expensive methods are used for the following stages (involving fewer genes).
There is good reason why the latest trends in the statistical analysis of clinical data are being initiated and analysed at the Department of Medical Studies at the Medical University of Vienna. Prof. Peter Bauer published a paper there in 1989 refuting a basic principle of biostatistics that the test design in an ongoing study must not be changed until the end. This evidence is and remains the basis for multi-stage adaptive analytical methods that have recently attracted worldwide research interest due to cost pressures in healthcare and are supported by the FWF in Austria.Image and text will be available online from Monday, 16th July 2007, 09.00 a.m. CET onwards:
Till C. Jelitto | alfa
Magic number colloidal clusters
13.12.2018 | Friedrich-Alexander-Universität Erlangen-Nürnberg
Record levels of mercury released by thawing permafrost in Canadian Arctic
13.12.2018 | University of Alberta
What if, instead of turning up the thermostat, you could warm up with high-tech, flexible patches sewn into your clothes - while significantly reducing your...
A widely used diabetes medication combined with an antihypertensive drug specifically inhibits tumor growth – this was discovered by researchers from the University of Basel’s Biozentrum two years ago. In a follow-up study, recently published in “Cell Reports”, the scientists report that this drug cocktail induces cancer cell death by switching off their energy supply.
The widely used anti-diabetes drug metformin not only reduces blood sugar but also has an anti-cancer effect. However, the metformin dose commonly used in the...
A research team from the University of Zurich has developed a new drone that can retract its propeller arms in flight and make itself small to fit through narrow gaps and holes. This is particularly useful when searching for victims of natural disasters.
Inspecting a damaged building after an earthquake or during a fire is exactly the kind of job that human rescuers would like drones to do for them. A flying...
Over the last decade, there has been much excitement about the discovery, recognised by the Nobel Prize in Physics only two years ago, that there are two types...
What if a sensor sensing a thing could be part of the thing itself? Rice University engineers believe they have a two-dimensional solution to do just that.
Rice engineers led by materials scientists Pulickel Ajayan and Jun Lou have developed a method to make atom-flat sensors that seamlessly integrate with devices...
12.12.2018 | Event News
10.12.2018 | Event News
06.12.2018 | Event News
13.12.2018 | Life Sciences
13.12.2018 | Physics and Astronomy
13.12.2018 | Earth Sciences